Question

In: Biology

Imagine that Arf1 protein was mutated so that it could not hydrolyze GTP, regardless of its...

Imagine that Arf1 protein was mutated so that it could not hydrolyze GTP, regardless of its binding partners. Would you expect COPI-coated vesicles to form normally? How would you expect transport mediated by COPI-coated vesicles to be affected? If this were the only form of Arf1 in a cell, would you expect it to be lethal? Briefly explain your answers.

Solutions

Expert Solution

Part 1) Would you expect COPI-coated vesicles to form?

Hydrolysis of GTP is an important step in the release of transportation vehicles. But on the other hand, GTP hydrolysis isn't required for the formation of vesicles.

What this mean is that, if ARF is bound to GTP (which is independent of its hydrolysis) it will not hydrolyse the GTP. When ARF hydrolyse the GTP it becomes GDP and ARF-GDP is an inactive form of ARF. Now since it's bound to ARF-GTP and it can not hydrolyse it, theoretically it will be activated all the time.

Activation of ARF by GTP initiate the formation of COPI coated vesicles. So inability of ARF to hydrolyse the GTP will not affect the formation of COPI coated vesicles.

To answer the question, COPI coated vesicles will form in this cell but ARF will be activated all the time, so vesicle formation will be higher than normal.

Part 2) How would you expect transport mediated by COPI coated vesicles to be affected

Now, Hydrolysis is the most important factor for the release of COPI coated vesicles from the membrane. Since this ARF can not hydrolyse the GTP, it will not stimulate the release of the vesicle from the membrane and the transport will be affected as no protein will be transported from the Golgi network.

Part 3)

Yes, this mutation will be lethal if there's only one copy of ARF in that cell.

Transportation of proteins is necessary for the cell survival as even though proteins will be synthesised by the cell, they will not reach their destination, i.e, Plasma membrane or Endoplasmic reticulum and this will effect the cell as these proteins are involved in every function of the cells. So in simpler terms, there will be no expression of those proteins which are transported by COPI coated vesicles and this may result in the death of the cell as some of those proteins maybe vital for the cell survival.


Related Solutions

Ras is a GTP-binding protein that is often mutated in cancer cells. Normal cells are stimulated...
Ras is a GTP-binding protein that is often mutated in cancer cells. Normal cells are stimulated to divide by receiving a signal from a growth factor through a receptor tyrosine kinase. When the receptor tyrosine kinase binds the growth factor, Ras is stimulated to bind GTP. Ras in turn activates proteins that promote cell proliferation. A common mutation in cancerous cells causes Ras to behave as though it were bound to GTP all the time. Suppose that there is a...
A single amino acid change in Ras eliminates its ability to hydrolyze GTP even in the...
A single amino acid change in Ras eliminates its ability to hydrolyze GTP even in the presence of a GTPase-activating protein (GAP). Roughly 30% of human cancers have this change in Ras. You have just identified a small molecule that prevents the dimerization of a receptor tyrosine kinase that signals via Ras. Would you expect this molecule to be effective in the treatment of cancers that express this common, mutant form of Ras? Why or why not? (Please give me...
A cell contains a mutation that prevent its' Gs proteins from being able to hydrolyze GTP....
A cell contains a mutation that prevent its' Gs proteins from being able to hydrolyze GTP. What is another likely way in which the cell could turn OFF the Gs signaling pathway? a) Remove all G-proteins from the cells b) Phosphorylate the beta-gamma complex c) Degrade cGMP d) Activate a Gi protein
A scientist mutates eIF-2 to eliminate its GTP hydrolysis capability. How would this mutated form of...
A scientist mutates eIF-2 to eliminate its GTP hydrolysis capability. How would this mutated form of eIF-2 alter translation?
1. Explain the transcription and translation mechanism of protein and the role of GTP in translation...
1. Explain the transcription and translation mechanism of protein and the role of GTP in translation process I want to know the answer of this question less than one page
Explain the transcription and translation mechanism of protein and the role of GTP in translation process
Explain the transcription and translation mechanism of protein and the role of GTP in translation process
What is the biochemical outcome of Zellweger's (disease) mutated protein? What is the biological consequence of...
What is the biochemical outcome of Zellweger's (disease) mutated protein? What is the biological consequence of the mutation? How does the mutation lead to a defective biochemical pathway that leads to the phenotype? Does the mutations affect the promoter? If so, explain
Oh No! One of the tRNA genes in E.coli was mutated so that the wrong amino...
Oh No! One of the tRNA genes in E.coli was mutated so that the wrong amino acid was charged onto it. Now, the amino acid that should be on the tRNA containing the anticodon 5'-CCA-3' is replaced with an Asp. DNA SEQUENCE: 5'-ATG TAG TTA TCC AAC CCT CCA AAA CAT GCA CCT CCT TAC TCA AGC AGG CAT ACG-3' a. Write out the protein sequence (using the DNA sequence from the problem above) that would be made in this...
Please provide detail explanation. Thank you. When a small GTP-binding protein (GBP) is in the "on"...
Please provide detail explanation. Thank you. When a small GTP-binding protein (GBP) is in the "on" (active) state (select any/all answers that apply): a) its Switch I and Switch II domains tilt toward one another b) GDP is bound within the nucleotide-binding pocket of the GBP c) the GBP is incapable of hydrolyzing its bound GTP d) the Switch II domain is phosphorylated on multiple tyrosine residues e) the GBP can physically interact with downstream effector molecules
How do we get from a ligand binding to a heterotrimeric GTP-binding protein to the activation...
How do we get from a ligand binding to a heterotrimeric GTP-binding protein to the activation of PKA?
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT